Mandatum Oyj Stock

Equities

MANTA

FI4000552526

Life & Health Insurance

Delayed Nasdaq Helsinki 11:29:46 2024-04-30 am EDT 5-day change 1st Jan Change
4.352 EUR -4.69% Intraday chart for Mandatum Oyj -0.37% +6.93%
Sales 2024 * 140M 149M Sales 2025 * 148M 158M Capitalization 2.18B 2.33B
Net income 2024 * 183M 195M Net income 2025 * 155M 165M EV / Sales 2024 * 15.6 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 14.8 x
P/E ratio 2024 *
11.9 x
P/E ratio 2025 *
13.9 x
Employees 694
Yield 2024 *
7.76%
Yield 2025 *
7.9%
Free-Float 97.89%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.69%
1 week-0.37%
Current month+5.01%
1 month+5.01%
3 months+2.64%
6 months+18.71%
Current year+6.93%
More quotes
1 week
4.33
Extreme 4.33
4.57
1 month
4.14
Extreme 4.143
4.57
Current year
3.83
Extreme 3.8285
4.57
1 year
3.28
Extreme 3.284
4.57
3 years
3.28
Extreme 3.284
4.57
5 years
3.28
Extreme 3.284
4.57
10 years
3.28
Extreme 3.284
4.57
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 23-03-28
Director of Finance/CFO 56 23-03-28
Chief Tech/Sci/R&D Officer 49 23-08-14
Members of the board TitleAgeSince
Director/Board Member 61 23-03-28
Chairman 58 23-03-28
Director/Board Member 63 23-03-28
More insiders
Date Price Change Volume
24-04-30 4.352 -4.69% 2,877,103
24-04-29 4.566 +3.77% 2,223,450
24-04-26 4.4 +1.15% 1,314,218
24-04-25 4.35 -1.61% 1,041,165
24-04-24 4.421 -0.20% 1,040,465

Delayed Quote Nasdaq Helsinki, April 30, 2024 at 11:29 am EDT

More quotes
Resulting from the spin-off of Sampo Oyj's asset and wealth management activity in October 2023, Mandatum Oyj specializes in financial services. The company offers asset and wealth management, savings and investment services, retirement plans and personal risk insurance to businesses, individuals and institutions.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
4.352 EUR
Average target price
3.9 EUR
Spread / Average Target
-10.39%
Consensus